Cost of revenue · 2018–2025

Castle Biosciences cost of revenue

$71.0M+18.0% · FY2025

Castle Biosciences (CSTL) reported $71.0M in cost of revenue for fiscal 2025, +18.0% year on year.

$5.3M2018$7.3M2019$9.7M2020$15.8M2021$32.0M2022$45.0M2023$60.2M2024$71.0M2025
Castle Biosciences — Cost of revenue, 2018–2025
Fiscal yearCost of revenueChangeFiling
FY20252025-12-31$71.0M+18.0%Open →
FY20242024-12-31$60.2M+33.8%Open →
FY20232023-12-31$45.0M+40.5%Open →
FY20222022-12-31$32.0M+102.3%Open →
FY20212021-12-31$15.8M+63.4%Open →
FY20202020-12-31$9.7M+32.5%Open →
FY20192019-12-31$7.3M+38.0%Open →
FY20182018-12-31$5.3M—Open →

Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2018–2025 compound annual growth +44.9%

Cost of revenue at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Castle Biosciences cost of revenue |url=https://companiesranked.com/en/company/castle-biosciences/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Castle Biosciences cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/castle-biosciences/cost-of-revenue

BibTeX

@misc{companiesranked-en-company-castle-biosciences-cost-of-revenue-2026,
  author       = {{CompaniesRanked}},
  title        = {{Castle Biosciences cost of revenue}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/castle-biosciences/cost-of-revenue}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001628280-26-012272 · February 26, 2026

{{cite web |title=Castle Biosciences cost of revenue — 10-K (0001628280-26-012272) |url=https://www.sec.gov/Archives/edgar/data/1447362/000162828026012272/cstl-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Castle Biosciences overview